4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-22-016929
Chief Business Officer, Global acquired 90,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Friedl-Naderer Johanna Chief Business Officer, Global | 2022-03-02 | Grant or award | +90,000 | 90,000 | D | ||
| Derivatives | |||||||
| Friedl-Naderer Johanna Chief Business Officer, Global | 2022-03-02 | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | D | ||
Loading xslF345X03/doc4.xml…